However, considering the role leptin plays in IR, fibrosis, and HCC, carefully monitored controlled studies with appropriate clinically relevant models need to be performed to use leptin inhibitors as a potential therapy for obesity-induced HCC. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.